rhabdomyolysis glp 1 Associated with the Use of Tirzepatide GLP-1 and the kidney: from

Frohlich, 2017

While some individuals report positive results after weeks to months of treatment, the temporary nature of effects, lack of regulatory approval, and documented adverse events warrant careful consideration

JacksonRDLaCroixAZGassMWallaceRBRobbinsJLewisCEet al

Copycat versions of Lilly's Mounjaro and Zepbound and Novo Nordisk's Wegovy and Ozempic have been widely available in recent years because the U.S

Family history of systemic lupus erythematosus and risk of autoimmune disease: nationwide cohort study in Denmark 19772013

These small studies also do not produce the same kind of safety data seen with larger, more rigorous studies